Aromatase Inhibition and Breast Cancer - W. Miller, R. Santeen
Presents evidence that letrozole, anastrozole, and exemestane have proven efficacy as second-line therapy and indicate increased antitumor effects and less toxicity than older aromatase inhibitors and progestins!
This reference provides a state-of-the-art assessment of drugs that inhibit the synthesis of estrogens-particularly agents used to treat breast cancer-and demonstrates how the endocrinological effects of the new generation of inhibitors translate into clinical benefits.
Trích dẫn:https://bit.ly/3fwVvuY
This site comply with DMCA digital copyright. We do not store files not owned by us, or without the permission of the owner. We also do not have links that lead to sites DMCA copyright infringement.
If You feel that this book is belong to you and you want to unpublish it, Please contact admin's email: xetnghiemdakhoa@gmail.com. Thanks!
Website: Medquizzes.net